# Cabenuva Injection Tracking in CHORUS

> **NCT04863261** · NA · COMPLETED · sponsor: **Epividian** · enrollment: 37 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **OTHER:** Cabenuva Scheduling Alerts in the Retention & Huddle modules of the CHORUS App

## Key facts

- **NCT ID:** NCT04863261
- **Lead sponsor:** Epividian
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863261, "Cabenuva Injection Tracking in CHORUS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04863261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*